[HTML][HTML] Potential treatments for COVID-19; a narrative literature review

A Rismanbaf - Archives of academic emergency medicine, 2020 - ncbi.nlm.nih.gov
SARS-CoV-2 is a newly emerging human infectious coronavirus that causes COVID-19,
which has been recognized as a pandemic by the World Health Organization (WHO) on …

[HTML][HTML] Evaluation of current therapies for COVID-19 treatment

A Sethi, H Bach - Microorganisms, 2020 - mdpi.com
The virus SARS-CoV-2, the etiological agent of COVID-19, is responsible for more than
400,000 deaths worldwide as of 10 June 2020. As a result of its recent appearance …

COVID-19 Pandemic: current Challenges and future Perspectives

S Saber, AE Khodir, AO Maghmomeh… - Research Journal of …, 2022 - indianjournals.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lead to the current
pandemic of coronavirus disease 2019 (COVID-19) and more than one hundred million …

[HTML][HTML] Anti COVID-19 drugs: need for more clinical evidence and global action

Z Khan, Y Karataş, H Rahman - Advances in therapy, 2020 - Springer
Abstract The World Health Organization (WHO) called the outbreak of coronavirus infectious
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …

[HTML][HTML] Current understanding of COVID-19 clinical course and investigational treatments

RB Aguilar, P Hardigan, B Mayi, D Sider… - Frontiers in …, 2020 - frontiersin.org
Importance: Currently, there is no unified framework linking disease progression to
established viral levels, clinical tests, inflammatory markers, and investigational treatment …

Systematic review on the therapeutic options for COVID-19: clinical evidence of drug efficacy and implications

AR Abubakar, IH Sani, B Godman… - Infection and drug …, 2020 - Taylor & Francis
Abstract A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and
quickly spread globally. Several treatments have been proposed, many of which have …

[PDF][PDF] Potential treatment options for COVID-19: a comprehensive review of global pharmacological development efforts

K Neupane, Z Ahmed, H Pervez, R Ashraf, A Majeed - Cureus, 2020 - cureus.com
Abstract Coronavirus disease-2019 (COVID-19), first reported in China during December of
2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

A global picture: therapeutic perspectives for COVID-19

VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Future Medicine
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …

COVID-19: learning from lessons to guide treatment and prevention interventions

CR Triggle, D Bansal, EABA Farag, H Ding, AA Sultan - MSphere, 2020 - Am Soc Microbiol
ABSTRACT Coronavirus disease 2019 (COVID-19) is caused by the novel coronavirus
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and first emerged in …

Use of antiviral agents and other therapies for COVID-19

MAT Blaskovich, AD Verderosa - Seminars in Respiratory and …, 2023 - thieme-connect.com
The coronavirus disease 2019 (COVID-19) pandemic led to a remarkably rapid
development of a range of effective prophylactic vaccines, including new technologies that …